Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BTRU-GEMS logo.jpg

2025

Fu MX, et al. 2025. Use of polyethylene glycol precipitation and ultracentrifugation to enhance the sensitivity of hepatitis B virus DNA detection. Journal of Clinical Virology

Torres Montaguth OE, et al. 2025. Nanopore-based hybridization capture approaches for targeted viral metagenomics and whole-genome sequencing. Preprint posted April 09, 2025 on medRxiv

Fu MX, et al. 2025. Occult hepatitis B virus infection: risk for a blood supply, but how about individuals' health? EClinicalMedicine.

Harvala H, et al. 2025. HTLV screening of blood donations in England between 2002 and 2021 – Comparison of screening strategies. Clinical Infectious Diseases.

Nurmi V, et al. 2025. Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial. J Infect.

2024

Fu MX, ET AL. 2024. A need for confirmatory testing of isolated HBcAb-positive results in screening programs.  Hepatol Commun. 

Mayne R, ET AL. 2024. Castanet: a pipeline for rapid analysis of targeted multi-pathogen genomic data. BIoinformatics.

Fu MX, ET AL. 2024. International review of blood donation screening for anti-HBc and occult hepatitis B virus infection. Transfusion.

Buddle S, et al. 2024. Evaluating metagenomics and targeted approaches for diagnosis and surveillance of viruses. Genome Med.

McClure CP, ET al. 2024. Reconstruction of the historic time course of blood-borne virus contamination of clotting factor concentrates, 1974-1992. J Med Virol. 

Fu M, et al. 2024. Blood donation screening for hepatitis B virus core antibodies: the importance of confirmatory testing and initial implication for rare blood donor groups. Vox Sanguinis.

Fu M, et al. 2024. Biomarkers of transfusion transmitted occult hepatitis B virus infection: Where are we and what next? Reviews in Medical Virology.

Stenbäck JB, et al. 2024. Accurate and cost-efficient whole genome sequencing of hepatitis B virus using Nanopore. posted October 09, 2024 on medRxiv.

2023

Gates S, ET AL. 2023. Investigating Blood Donors With Postdonation Respiratory Tract Symptoms During the Wild-Type, Delta, and Omicron Waves of the Coronavirus Disease 2019 Pandemic in England. OPEN FORUM INFECTIOUS DISEASES.

Fu M, Et AL. 2023. Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors. J MED VIROL.

Rosadas C, et al. 2023. HTLV-1 screening of blood donations: We are systematically missing opportunities. BJHAEM.

Gates S, ET AL.. 2023. 'Postpandemic rebound of adeno-associated virus type 2 (AAV2) infections temporally associated with an outbreak of unexplained severe acute hepatitis in children in the United Kingdom. J Med Virol.

Nurmi V, ET AL. 2023. The relationship between SARS-CoV-2 neutralising antibody titres and avidity in plasma collected from convalescent non-vaccinated and vaccinated blood donors. J Infect Dis. 

Maddox V, ET AL. 2023. Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEP. Transfusion Medicine. 

MADDOX V, ET AL. 2023. Undeclared pre-exposure or post-exposure prophylaxis (PrEP/PEP) use among syphilis-positive blood donors, England, 2020 to 2021. Eurosurveillance. 

KNIGHT C ET AL., 2023. 'ABSENCE OF DETECTABLE MONKEYPOX VIRUS DNA IN 11,000 ENGLISH BLOOD DONATIONS DURING THE 2022 OUTBREAK'. TRANSFUSION. 

MORFOPOULOU S ET AL., 2023. 'GENOMIC INVESTIGATIONS OF ACUTE HEPATITIS OF UNKNOWN AETIOLOGYIN CHILDREN'. Nature

2022

Harvala H and SiMmonds P. 2022. 'Evaluating the risk of transfusion and transplant-transmitted monkeypox infections'. TRANSFUSION MED.

Publications in support of BTRU-GEMS grant application

Ratcliff et al. 2022. ‘Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR’. JC Microbiology.

Mehew et al. 2022. ‘Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titres’. Transfusion Med.

Blackstone et al. 2022. ‘Protocol for the COG-UK hospital-onset COVID-19 infection (HOCI) multicentre interventional clinical study: evaluating the efficacy of rapid genome sequencing of SARS-CoV-2 in limiting the spread of COVID-19 in UK NHS hospitals’. BMJ Open.

Pitt et al. 2022. ‘Whole-genome sequencing of Chlamydia trachomatis isolates from persistently infected patients’. Int J STD AIDS.

Harvala et al. 2021. ‘Hepatitis B infections among blood donors in England between 2009 and 2018: Is an occult hepatitis B infection a risk for blood safety?’. Transfusion.